Goods and Services: IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and biotechnological preparations and substances for human medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; veterinary preparations and substances for animal medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; diagnostic preparations for medical use and reagents for medical use, namely, for diagnosis of human diseases, such as cancer and autoimmune diseases; pharmaceutical and biotechnological preparations, namely, antibodies for the treatment of cancers and autoimmune diseases; pharmaceutical and biotechnological preparations, namely, antibody fragments and antibody conjugates for the treatment of cancers and autoimmune diseases; pharmaceutical and biotechnological preparations for the reconstruction and repair of antibodies for use in the field of cancers and autoimmune diseases; monoclonal antibodies for medical and veterinary use, namely, reagents for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; proteins for medical use, namely, for detecting antibodies; clinical medical reagents, namely, reagents for use in the development of monoclonal antibodies; proteins for medical use, namely, for binding antibodies; reagents for veterinary use, namely, reagents for the development of monoclonal antibodies; vaccines; vaccines against cancer, viral infection and bacterial infection, vaccines for human use; vaccine adjuvants; medical and veterinary diagnostic reagents, namely, reagents for use in tests for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; reagents for research purposes, namely, diagnostic reagents for medical research applications; cells for medical or clinical use, namely, recombinant human protein production cell lines. proteins for medical use in the field of recombinant DNA technology; biological reagents for medical purposes in the field of molecular biology
IC 042. US 100 101. G & S: Scientific research and development, clinical research and scientific advisory and consultancy services all in relation to antibody production; drug discovery; research and development of vaccines, namely, vaccine screening; scientific research advisory services relating to diagnostic products for diagnosing cancers and autoimmune diseases; diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the field of science; medical research services; scientific research for medical purposes; pharmaceutical research services; scientific research advisory services comprising the preparation of reports relating to the performance and analysis of research and the outcomes of research in the field of pharmaceuticals and biotechnology; biochemical, chemical, microscopy, spectroscopy, physiological, histological, and electrical analysis of biological tissues for medical research; scientific research and development services for the production of antibodies; scientific research and development services for the discovery and development of proteins that bind to antibodies